Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

CVKD

Cadrenal Therapeutics (CVKD)

Cadrenal Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CVKD
DateTimeSourceHeadlineSymbolCompany
01/01/202500:00Business WireCadrenal Therapeutics Provides 2024 Year-End Company Update, Reinforcing Clinical Development Plan for Tecarfarin in LVAD and Other Rare Cardiovascular IndicationsNASDAQ:CVKDCadrenal Therapeutics Inc
24/12/202408:44Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CVKDCadrenal Therapeutics Inc
21/12/202409:28Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CVKDCadrenal Therapeutics Inc
19/12/202401:00Business WireCadrenal Therapeutics Gears Up for the 43rd Annual J.P. Morgan Healthcare Conference Week with Event Participation and Investor/Partner MeetingsNASDAQ:CVKDCadrenal Therapeutics Inc
26/11/202408:53Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CVKDCadrenal Therapeutics Inc
25/11/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CVKDCadrenal Therapeutics Inc
20/11/202401:00PR Newswire (US)Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech OutlookNASDAQ:CVKDCadrenal Therapeutics Inc
15/11/202408:05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CVKDCadrenal Therapeutics Inc
15/11/202401:00Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:CVKDCadrenal Therapeutics Inc
13/11/202401:00PR Newswire (US)CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESSNASDAQ:CVKDCadrenal Therapeutics Inc
08/11/202408:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CVKDCadrenal Therapeutics Inc
08/11/202401:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CVKDCadrenal Therapeutics Inc
08/11/202401:00PR Newswire (US)CADRENAL THERAPEUTICS PROVIDES THIRD-QUARTER CORPORATE UPDATENASDAQ:CVKDCadrenal Therapeutics Inc
05/11/202408:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CVKDCadrenal Therapeutics Inc
05/11/202401:13Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CVKDCadrenal Therapeutics Inc
05/11/202401:13Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CVKDCadrenal Therapeutics Inc
02/11/202411:00PR Newswire (US)Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross ProceedsNASDAQ:CVKDCadrenal Therapeutics Inc
25/10/202400:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CVKDCadrenal Therapeutics Inc
25/10/202400:00PR Newswire (US)Cadrenal Therapeutics Raises $5.1 Million via At-The-Market FacilityNASDAQ:CVKDCadrenal Therapeutics Inc
24/10/202400:00PR Newswire (US)CADRENAL THERAPEUTICS JOINS CORPORATE COUNCIL OF ANTICOAGULATION FORUMNASDAQ:CVKDCadrenal Therapeutics Inc
05/10/202406:15Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CVKDCadrenal Therapeutics Inc
26/09/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CVKDCadrenal Therapeutics Inc
24/09/202406:15PR Newswire (US)Cadrenal Therapeutics to Participate in Lytham Partners Fall 2024 Investor ConferenceNASDAQ:CVKDCadrenal Therapeutics Inc
06/09/202406:59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CVKDCadrenal Therapeutics Inc
22/08/202423:00PR Newswire (US)Cadrenal Therapeutics Announces Upcoming Type-B FDA Meeting in September to Discuss Tecarfarin Trial in LVAD PatientsNASDAQ:CVKDCadrenal Therapeutics Inc
20/08/202423:00PR Newswire (US)Published Findings Highlight Tecarfarin's Potential and Reinforce Need for Better Anticoagulation Therapy in LVAD PatientsNASDAQ:CVKDCadrenal Therapeutics Inc
20/08/202420:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CVKDCadrenal Therapeutics Inc
16/08/202420:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CVKDCadrenal Therapeutics Inc
14/08/202423:00PR Newswire (US)Cadrenal Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:CVKDCadrenal Therapeutics Inc
09/08/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CVKDCadrenal Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CVKD